healthcare
healthcare Articles
Taiwan Liposome has enrolled its first subject for its coronavirus treatment that includes the controversial hydroxychloroquine.
Published:
When cash is king, selling off a portion of the business or finding a way to raise capital can be crucial to continuing operations.
Published:
UnitedHealth posted better than expected third-quarter financial results before the markets opened on Wednesday, but shares retreated afterward.
Published:
Health care is one sector that continues to draw a ton of fund manager interest, and with good reason. These five dividend-paying health care stocks are all favored by large-cap portfolio managers.
Published:
Gossamer Bio shares dived on Tuesday after the company announced midstage results from its asthma and chronic rhinosinusitis studies.
Published:
Johnson & Johnson released better than expected quarterly results before the markets opened on Tuesday, but it also announced a pause in its late-stage coronavirus vaccine trial.
Published:
The September 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
Medical device company Spinal Elements Holdings intends to price more than 7 million shares for an initial public offering valued up to almost $133 million.
Published:
Applied Therapeutics shares pushed higher on Thursday after a new analyst report came out supposing massive upside for this biotech.
Published:
Taiwan Liposome shares shot up on Wednesday after the firm announced that it would be able to move forward with its COVID-19 trial that uses hydroxychloroquine.
Published:
Eli Lilly shares made a handy gain on Wednesday after the company announced an update to its SARS-CoV-2 neutralizing antibody programs.
Published:
Announcements that Alexion Pharmaceuticals made at its virtual Investor Day about expanding its pipeline and its guidance led to a handy gain in its shares on Tuesday.
Published:
Vir Biotechnology shares jumped on Tuesday after the firm announced that it would be expanding its late-stage COVID-19 study in conjunction with GlaxoSmithKline.
Published:
ImmunoGen shares pushed higher to start out the week when the FDA provided an update for the firm’s treatment of patients with relapsed or refractory blastic plasmacytoid dendritic cell neoplasm.
Published:
Nvidia has announced it will partner with GlaxoSmithKline to apply its artificial intelligence and supercomputers for the drug and vaccine discovery process.
Published: